Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: Similarities and differences

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 876-884

  Rey, Enrique ^a   Balboa, Agustín ^b   Mearin, Fermín ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CENTRO MÉDICO TEKNON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CHRONIC CONSTIPATION; CONSTIPATION; CONSULTATION; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; IRRITABLE COLON; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIVE IN CONSTIPATION 20 QUESTIONNAIRE; QUESTIONNAIRE; ROME III QUESTIONNAIRE; SELF REPORT; SEX RATIO; SHORT FORM 12; TELEPHONE INTERVIEW;

CONSTIPATION; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 84902119059     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.18     Document Type: Article

References (44)

1. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: Relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999;94;3530-40
2. Higgins PD, Johanson JF. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol 2004;99;750-9. (Pubitemid 38612817
3. Johanson JF, Kralstein J. Chronic constipation: A survey of the patient perspective. Aliment Pharmacol Ther 2007;25;599-608
4. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: A study of prevalence and potential risk factors. Am J Gastroenterol 1996;91;19-25. (Pubitemid 26026031
5. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel s í ndrome: An international survey on 40000 subjects. Aliment Pharmacol Ther 2003;17;643-50. (Pubitemid 36418887
6. Choung RS, Locke GR III. Epidemiology of IBS. Gastroenterol Clin North Am 2011;40;1-10
7. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-Analysis. Am J Gastroenterol 2011;106;1582-91
8. Mearin F, Bad í a X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36;1155-61. (Pubitemid 32917583
9. Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: Are we getting closer to the' true ' prevalence of irritable bowel syndrome?. Eur J Gastroenterol Hepatol 2007;19;441-7
10. Garrigues V, Gálvez C, Ortiz V, et al. Prevalence of constipation: Agreement among several criteria and evaluation of the diagnostic accuracy of qualifying symptoms and self-reported defi nition in a population-based survey in Spain. Am J Epidemiol 2004;159;520-6. (Pubitemid 38280299
11. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130;1480-91
12. Kamm MA, Müller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005;100;362-72. (Pubitemid 40314521
13. Novick J, Miner P, Krause R, et al. A randomized, double-blind, placebocontrolled trial of tegaserod in female patients suff ering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002;16;1877-88
14. Johanson JF, Morton D, Geenen J, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-Acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008;103;170-7
15. Drossman DA, Chey WD, Johanson JF, et al. Clinical trial: Lubiprostone in patients with constipation-Associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther 2009;29;329-41
16. Ford A, Brandt L, Young C, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: Systematic review and meta-Analysis. Am J Gastroenterol 2009;104;1831-43
17. Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011;365;527-36
18. Johnston JM, Kurtz CB, MacDougall JE, et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 2010;139;1877-86
19. Drossman DA, Morris C, Hu Y, et al. Further characterization of painful constipation (PC): Clinical features over one year and comparison with IBS. J Clin Gastroenterol 2008;42;1080-8
20. Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol 2010;105;2228-34
21. Drossman DA, Corazziari E, Delvaux M, et al. Apéndice B: Criterios diagnósticos de Roma III para los trastornos funcionales gastrointestinales. Rev Gastroenterol Mex 2010;75;511-6
22. Moreno Elola-Olaso C, Rey E, Rodr í guez-Artalejo F, et al. Adaptation and validation of a gastroesophageal refl ux questionnaire for use on a Spanish population. Rev Esp Enf Digest 2002;94;745-51
23. Alonso J, Regidor E, Barrio G, et al. Valores poblacionales de referencia de la versión espa ñ ola del Cuestionario de Salud SF-36. Med Clin Barc 1998;111;410-6. (Pubitemid 128524827
24. BarcelóM, Jimenez-Cebrian MJ, D í az-Rubio M, et al. Validation of a questionnaire for assessing fecal impaction in the elderly: Impact of cognitive impairment, and using a proxy. BMC Geriatr 2013;13;24
25. Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002;20;749-58. (Pubitemid 35034443
26. Perona M, Mearin F, Guilera M, et al. Quality of life specifi c questionnaire for constipated patients: Development and validation of CVE-20. Med Clin (Barc) 2008;131;371-7
27. Talley NJ, Holtmann G, Agréus L, et al. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: A four nations study. Am J Gastroenterol 2000;95;1439-47. (Pubitemid 30396300
28. Guthrie E, Creed F, Fernandes L, et al. Cluster analysis of symptoms and health seeking behaviour diff erentiates subgroups of patients with severe irritable bowel syndrome. Gut 2003;52;1616-22. (Pubitemid 37363447
29. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101;927-34
30. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992;304;87-90
31. Locke GR III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17;29-44
32. Sorouri M, Pourhoseingholi MA, Vahedi M, et al. Functional bowel disorders in an Iranian population using Rome III criteria. Saudi J Gastroenterol 2010;16;154-60
33. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: A population-based study. Am J Gastroenterol 2002;97;2290-9
34. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: Systematic review and meta-Analysis. Gut 2011;60;209-18
35. Johanson JF, Drossman DA, Panas R, et al. Clinical trial: Phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2008;27;685-96. (Pubitemid 351406304
36. Manabe N, Rao AS, Wong BS, et al. Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep 2010;12;408-16
37. Markland AD, Palsson O, Goode PS, et al. Association of low dietary intake of fi ber and liquids with constipation: Evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol 2013;108;796-803
38. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fi ber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol 2003;98;1790-6. (Pubitemid 36959160
39. Locke GR III, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology 2000;119;1766-78. (Pubitemid 32198703
40. Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol 2007;5;1053-8
41. Choung RS, Branda ME, Chitkara D, et al. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther 2011;33;251-60
42. Belsey J, Greenfi eld S, Candy D, et al. Systematic review: Impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010;31;938-49
43. Gálvez C, Garrigues V, Ortiz V, et al. Healthcare seeking for constipation: A population-based survey in the Mediterranean area of Spain. Aliment Pharmacol Ther 2006;24;421-8. (Pubitemid 43972911
44. Müller-Lissner S, Tack J, Feng Y, et al. Levels of satisfaction with current chronic constipation treatment options in Europe-An internet survey. Aliment Pharmacol Ther 2013;37;137-45